Top News
K-Bio Targets the U.S. Market: Celltrion and Samsung Bioepis Close in...
Celltrion and Samsung Bioepis are expanding in the U.S. market, showing strong growth in biosimilars like Zymfentra and Hadlima.
- Our Sponsors Ad -